Choose from one of the dates below to find a complete list of presentations for the 2015 NAPSGHAN Annual Meeting.
Wednesday, October 7 - Single Topic Symposium: STOPNASH
Patterns of NAFLD around the world
Jeff Schwimmer MD, University of California, San Diego
Putting NAFLD in perspective: An overview of the pathophysiology
Brent A. Neuschwander‐Tetri MD, St. Louis University
Genetics plus the environment: The sugar effect on PNPLA3
Michael Goran MD, Keck School of Medicine, University of Southern California
NAFLD andhttps://naspghan.org/ Type II Diabetes
Sonia Caprio MD, Yale University School of Medicine
Maternal insulin resistance and NAFLD development
Jed Friedman MD, University of Colorado School of Medicine
Fatty acid dysregulation in NAFLD
Elizabeth Parks MD, University of Missouri School of Medicine
Fructose and the liver: More than just extra calories?
Rob Lustig MD, University of California, San Francisco
Microbiome and NAFLD in children
Marialena Mouzaki MD, The Hospital for Sick Children
Genetics and NAFLD: What we know so far
Nicola Santoro MD, Yale University School of Medicine
Crosstalk between adipocytes and hepatocytes
Nitika Gupta MD, Emory University
Oxidized lipids and linoleic acid in NASH
Christopher Ramsdam MD, National Institutes of Health
Sterile inflammation and cell death
Ariel Feldstein MD, University of California, San Diego
NASH: What's bile got to do with it?
Rohit Kohli MD, Cincinnati Children's Hospital Medical Center
What dose of exercise reduces insulin resistance in children and application to NAFLD
Catherine Davis MD, Georgia Regents University
Interventions and policies to prevent obesity among vulnerable children
Jennifer Woo Baidal MD, Boston Children's Hospital
Prevention and treatment of childhood obesity: What can we learn and apply to prevention of NAFLD?
Sarah Barlow MD, Baylor College of Medicine
Goals of the NASH CRN and opportunities for collaboration
Joel Lavine MD, Columbia University
NIDDK priorities and perspectives
Ed Doo MD, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Opportunities for Collaboration
Veronica Miller PhD, Director, Forum for Collaborative HIV Research and The Liver Forum
Friday, October 9
FULMINANT COLITIS: DO WE NEED TO CHANGE OUR CURRENT PARADIGM?
Jeffrey Hyams MD and Brendan Boyle MD
FUNCTIONAL ABDOMINAL PAIN: IMPLEMENTING NONPHARMACOLOGIC THERAPIES INTO YOUR PRACTICE
Bruno Chumpitazi MD and Miranda Van Tilburg PhD
RECALCITRANT GER
Benjamin Gold MD and Hayat Mousa MD
EoE AND ELIMINATION DIETS
Amir Kagalwalla MD and Sally Schwartz RD
PUTTING ASSESSMENT OF ENDOSCOPIC COMPETENCE INTO PRACTICE
Catharine Walsh MD and Jenifer Lightdale MD
FORMULA MANAGEMENT AND ENTERAL FEEDING
Valeria Cohran MD and Monique L Goldschmidt MD
ACUTE PANCREATITIS: BASIC MANAGEMENT AND BEYOND
Aliye Uc MD and Bradley Barth MD
DOLOR ABDOMINAL FUNCTIONAL: TODOS LOS ESTUDIOS SON NORMALES, PERO EL DOLOR SEVERO CONTINÚA. ¿AHORA QUE HAGO? (No charge)
Samuel Nurko MD and Jose Garza MD
BASIC SCIENCE YEAR IN REVIEW
Nicola Jones MD, PhD, The Hospital for Sick Children
CLINICAL SCIENCE YEAR IN REVIEW
William Balistreri MD, Cincinnati Children’s Hospital Medical Center
THE EOE HUNGER GAMES: PPI-REE IS CATCHING FIRE!
Edaire Cheng MD, UT Southwestern Medical Center
USE OF CONCOMITANT IMMUNOMODULATORS AND ANTI-TNFS: EMERGING INSIGHTS
Laurie Conklin MD, Children’s National Medical Center
INTRACTABLE CONSTIPATION: WHAT IS NEXT WHEN YOU ARE STUCK?
Jose Garza MD, Children’s Center for Digestive Healthcare, Atlanta
WHEN THE GOING GETS TOUGH: IMPROVING OUTCOMES OF COLONOSCOPY
Jenifer Lightdale MD, UMass Memorial Children’s Hospital
NASPGHAN Endoscopy Prize
SELF-ASSESSMENT ACCURACY OF PEDIATRIC ENDOSCOPISTS: A PROSPECTIVE CROSS SECTIONAL STUDY.
Catharine M. Walsh1, Simon C. Ling1, Jenifer R. Lightdale2, Petar Mamula3, Heather Carnahan4. 1Division of Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, Hospital for Sick Children, Toronto, ON, Canada; 2Division of Pediatric Gastroenterology and Nutrition, UMass Memorial Children's Medical Center, Worcester, MA, USA; 3Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital of Philadelphia, Philadelphia, PA, USA; 4School of Human Kinetics and Recreation, Memorial University of Newfoundland, St. John's, NF, Canada.
POLYPECTOMY: WHO, WHEN, WHY AND HOW
Seth Septer MD, Children’s Mercy Hospital
UTILITY OF ROUTINE COLONIC BIOPSIES DURING PEDIATRIC COLONOSCOPIC POLYPECTOMY FOR BENIGN JUVENILE INFLAMMATORY POLYPS.
Michael A. Malandra, Sunpreet Kaur, Ashish Chogle. Gastroenterology, Hepatology, and Nutrition, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA.
ADVANCES IN CF THERAPIES AND THEIR EFFECT ON GASTROINTESTINAL MANIFESTATIONS
Daniel Gelfond MD, WNY Pediatric Gastroenterology
IDENTIFICATION OF ION TRANSPORT DEFECTS RESPONSIBLE FOR SECRETORY DIARRHEA IN MICROVILLUS INCLUSION DISEASE (MVID)
Nadia Ameen, Dmitri Kravtsov. Pediatrics, Yale University School Medicine, Branford, CT, USA.
DISCORDANT SEROLOGIES AND BIOPSIES: WHAT TO DO?
Dascha C. Weir MD, Boston Children's Hospital
POOR SENSITIVITY OF TTG FOR PREDICTING MUCOSAL HEALING IN CHILDREN WITH CELIAC DISEASE ON A GLUTEN FREE DIET.
Maureen M. Leonard1, Prashant Singh2, Alessio Fasano1. 1Pediatric Gastroenterology and Nutrition, MassGeneral Hospital for Children, Boston, MA, USA; 2Internal Medicine, Massachusetts General Hospital, Boston, MA, USA.
LONG TERM COMPLICATIONS OF TPN: NOW THAT MY INTESTINAL FAILURE PATIENTS ARE NOT DYING OF LIVER DISEASE, WHAT ELSE SHOULD I WORRY ABOUT?
Jane Balint MD, Nationwide Children’s Hospital
NASPGHAN Nutrition Prize
ETHANOL LOCK THERAPY IN CHILDREN WITH INTESTINAL FAILURE: INFECTION PREVENTION AND VASCULAR PRESERVATION.
Danielle Wendel1, Anne Reilly1,2, Susan Coffin1,2, Maria Mascarenhas1,2, Millie Boettcher1, Cynthia Wildes1, Natalie Terry1,2, Joy Collins1,2, Christina Bales1,2. 1Children's Hospital of Philadelphia, Philadelphia, PA, USA;2University of Pennsylvania, Philadelphia, PA, USA.
COMBATING CLABSIS-PREVENTING CENTRAL LINE INFECTIONS AND OTHER CENTRAL LINE CHALLENGES
John Kerner MD, Lucile Packard Children’s Hospital
NASPGHAN Foundation/Nestle Nutrition Young Investigator Development Award
UNRAVELING METABOLIC DYSADAPTATION IN MALNUTRITION: FROM CELLULAR MECHANISMS TO IMPROVED CHILD SURVIVAL
Robert Bandsma, The Hospital for Sick Children, Toronto, ON
DEMYSTIFYING THE IND
Kerry Jo Lee MD, Food and Drug Administration
Kevin Bugin MD, Food and Drug Administration
THE INVESTIGATOR AS SPONSOR
James Heubi MD, Cincinnati Children’s Hospital and Medical Center
POST-OPERATIVE MANAGEMENT IN PEDIATRIC CROHN’S DISEASE: HOW SHOULD THE PEDIATRIC GASTROENTEROLOGIST APPROACH THIS IN 2015?
Sandy Kim MD, Nationwide Children’s Hospital
INFLIXIMAB DOSING STRATEGIES AND TROUGH EXPOSURE IN CHILDREN WITH CROHN'S DISEASE
Adam Frymoyer, K. T. Park. Stanford University, Palo Alto, CA, USA.
STATE OF THE ART RESEARCH LECTURE - VERY EARLY ONSET IBD IN CHILDREN: CAUSES, CURES, & CONUNDRUMS
Scott Snapper MD, Boston Children’s Hospital
INCREASED EXPRESSION OF LRRK2, A SUSCEPTIBILITY GENE OF IBD RESULTS IN SUPPRESSION OF AUTOPHAGY AND ENHANCED INNATE IMMUNE RESPONSES MEDIATING COLITIS.
Tetsuya Takagawa1,2, Masaki Tajima1, Kazutoshi Hori2, Shiro Nakamura2, Atsushi Kitani1, Ivan J. Fuss1, Warren Strober1. 1Mucosal Immunity, National Institutes of Health, Bethesda, MD, USA; 2Department of Inflammatory Bowel Disease, Hyogo College of Medicine, Nishinomiya, Japan
SHOCKING THE GASTROINTESTINAL TRACT: ELECTRICAL STIMULATION FROM TOP TO BOTTOM
Steve Teich MD, Nationwide Children’s Hospital
STUDY OF PEG 3350 IN PEDIATRIC POPULATION.
Kent Williams1, Lynette Rogers2, Han Yin2, Ivor Hill1, John Barnard1,2, Christopher Coss3, Carlo DiLorenzo1.1Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, OH, USA;2The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA; 3College of Pharmacy, The Ohio State University, Columbus, OH, USA.
STATE OF THE RESEARCH ART LECTURE - BUGGING THE GASTROINTESTINAL TRACT: MICROBIOME AND THE ENTERIC NERVOUS SYSTEM
Elyanne Ratcliffe MD, McMaster University
NASPGHAN Foundation/George Ferry Young Investigator Award
DEFINING THE ROLE OF GLIAL CELLS IN THE ENTERIC NERVOUS SYSTEM
Meenakshi Rao MD, PhD, Columbia University Medical Center
BACTERIAL OVERGROWTH IN PEDIATRIC SHORT BOWEL SYNDROME
Conrad Cole MD, Cincinnati Children’s Hospital Medical Center
THE BACTERIAL COMMUNITY OF THE SMALL INTESTINE IN CHILDREN WITH SHORT BOWEL SYNDROME.
Brittany E. Goldberg1, Steven Zeichner3, Emmanuel Mongodin4, John Huang3, Clarivet Torres2. 1Pediatric Infectious Diseases, Children's National Medical Center, Washington, DC, USA; 2Intestinal Rehabilitation Program, Children's National Medical Center, Washington, DC, USA; 3Center for Cancer and Immunology Research, Children's National Medical Center, Washington, DC, USA; 4Institute for Genome Sciences, University of Maryland, Baltimore, MD, USA.
STATE OF THE RESEARCH ART LECTURE - CUTTING EDGE OR CRAZY: IS SURGERY THE MOST EFFECTIVE TREATMENT FOR NASH?
Stavra Xanthakos MD, Cincinnati Children’s Hospital Medical Center
NASPGHAN Foundation/Takeda Pharmaceuticals Products, Inc Research Innovation Award
NASH IMPROVEMENT AFTER BARIATRIC SURGERY: THE ROLE OF BILE ACID SIGNALING
Rohit Kohli MD, Cincinnati Children’s Hospital Medical Center
SWALLOWING PROBLEMS IN INFANTS AND TODDLERS: TESTING AND TREATMENT
Richard Noel MD, Duke University Medical Center
APFED Outstanding EGID Abstract Award
EMPIRIC FOUR FOOD ELIMINATION DIET INDUCES REMISSION IN PEDIATRIC EOSINOPHILIC ESOPHAGITIS AND SUBSEQUENT REINTRODUCTION IDENTIFIES FOOD TRIGGERS.
Amir Kagalwalla1,2, Katie Amsden1, Melanie M. Makhija1, Joshua B. Wechsler1, Anthony Olive3, Sally Schwartz1, Carla Davis3, Kristin Johnson1, Marion Groetch4, Mary Ellen Riffle4, Maria Manuel-Rubio1, Hector Melin-Aldana5, Barry Wershil1, Margaret Collins6, Mirna Chehade4. 1Pediatrics, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA; 2Department of Pediatrics, John H. Stroger Hospital of Cook County, Chicago, IL, USA; 3Pediatric Medicine, Texas Children's Hospital, Houston, TX, USA; 4Icahn School of Medicine at Mount Sinai, New York, NY, USA; 5Department of Pathology, Ann & Robert H. Lurie Children's Hospital of Chicago, Chicago, IL, USA; 6Division of Pathology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
APPROACH TO THE PATIENT WITH DYSPHAGIA: WHEN IT'S NOT EoE…
Manu Sood MD, Children’s Hospital of Wisconsin
APFED Outstanding EGID Abstract Award
CHEMICAL AND MECHANICAL STIMULI DRIVE ESOPHAGEAL FIBROBLAST ACTIVITY: IMPLICATIONS FOR EOE FIBROSIS.
Amanda Muir1, Kara Dods1, Alain J. Benitez1, Steven Henry2, Dale Lee3, Kelly Whelan4, Maureen DeMarshall4, Daniel Hammer2, Gary Falk4, Rebecca G. Wells4, Jonathan Spergel5, Hiroshi Nakagawa4, Mei-Lun Wang1. 1GI, The Children's Hospital of Philadelphia, Philadelphia, PA, USA; 2Department of Engineering, University of Pennsylvania, Philadelphia, PA, USA; 3Gastroenterology, Seattle Children's Hospital, Seattle, WA, USA;4Gastroenterology, University of Pennsylvania, Philadelphia, PA, USA; 5Allergy, The Children's Hospital of Philadelphia, Philadelphia, PA, USA.
HARNESSING THE POWER OF INDIVIDUAL AND ORGANIZED ADVOCACY
Tom Sheridan
THE EFFECTIVE ADVOCATE: A VIEW FROM CAPITOL HILL
Ron Grimes
WHAT DOES IT MEAN TO BE A PATIENT ADVOCATE?
George Ferr
BLACK BOXES AND OTHER WARNINGS
Harland Winter MD, Massachusetts General Hospital for Children
PEDS GI AND THE FDA
Andrew Mulberg MD, FDA
DRUGS IN THE MEDIA
John Pohl MD, Primary Children's Hospital
You can now view the full video of the 2015 LASPGHAN Session.
WELCOME BY NASPGHAN'S INTERNATIONAL COMMITTEE
Chair: Miguel Saps MD
INVITATION AND INFORMATION ON LASPGHAN ANNUAL MEETING
Eduardo Hebel, MD, LASPGHAN's President
NON-CELIAC GLUTEN SENSITIVITY AND FODMAP DIET: MYTH OR REALITY?
Bruno Chumpitazi MD, Texas Children's Hospital
ENDOSCOPIC MANAGEMENT OF GASTROINTESTINAL BLEEDING AND FOREIGN BODIES IN CHILDREN
Antonio J Quiros MD, Medical University of South Carolina
DEBATE: EOSINOPHILIC ESOPHAGITIS
Moderator: Eduardo Hebel MD
Richard Noel MD, Chief, Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Duke University School of Medicine
Samuel Nurko MD, MPH, Director, Center for Motility and Functional Gastrointestinal Disorders, Boston Children's Hospital
NEW ADVANCES: DIAGNOSTIC AND THERAPEUTIC PERSPECTIVES IN EOSINOPHILIC ESOPHAGITIS
Eitan Rubinstein MD, Boston Children's Hospital
ABSTRACT AWARD PRESENTATION
Saturday, October 10
THANKS BUT NO THANKS: DEALING WITH REFUSAL OF MEDICALLY NECESSARY TREATMENT
Sylviane Forget MD and William Wenner MD
CROHN’S DISEASE: COMPLICATED CASES
Athos Bousvaros MD and Brian P. Regan Sr. DO
MEET THE FDA
Andrew Mulberg MD and Juli Tomaino, MD, Jessica Lee, MD and Kerry Jo Lee, MD
TRANSITION TO TRANSFER OF CARE
Laurie Fishman MD and Nitika Gupta MD
HEPATITIS B
Phil Rosenthal MD and Douglas Mogul MD
MANAGEMENT OF GASTROINTESTINAL AND NUTRITIONAL MANIFESTATIONS OF CYSTIC FIBROSIS
Maria Mascarenhas MBBS and Meghana Sathe, MD
HOW TO ACE THE ACE
Leonel Rodriguez MD, Jason Dranove MD and Sheila Bell
LA B DE HEPATITIS EN NIÑOS (no charge)
Regino Gonzalez Peralta MD and Aymin Delgado-Borrego MD, MP
Fellow Research Award
AN INNOVATIVE MUCOSAL IMPEDANCE DEVICE DIFFERENTIATES ACTIVE EOSINOPHILIC ESOPHAGITIS FROM INACTIVE DISEASE, NERD, AND CONTROLS.
Mary Allyson Lowry1, Michael F. Vaezi2, Hernan Correa3, Tina Higginbotham2, James C. Slaughter4, Sari Acra1.1Pediatric Gastroenterology, Vanderbilt University, Nashville, TN, USA; 2Gastroenterology, Vanderbilt University, Nashville, TN, USA; 3Pediatric Pathology, Vanderbilt University, Nashville, TN, USA; 4Biostatistics, Vanderbilt University, Nashville, TN, USA.
Young Faculty Investigator Award
LOSS OF NUCLEAR RECEPTOR LRH-1 SENSITIZES INTESTINAL EPITHELIUM TO INFLAMMATORY INJURY.
James R. Bayrer1, Robert Fletterick2, Ophir Klein4, Holly Ingraham3. 1Pediatric Gastroenterology, U.C. San Francisco, San Francisco, CA, USA; 2Biochemistry and Biophysics, U.C. San Francisco, San Francisco, CA, USA;3Cellular and Molecular Pharmacology, U.C. San Francisco, San Francisco, CA, USA; 4Orofacial Sciences and Pediatrics, U.C. San Francisco, San Francisco, CA, USA.
KEYNOTE ADDRESS: 21ST CENTURY HEALTH CARE POLITICS AND THE CHALLENGES THEY POSE TO PEDIATRIC ACADEMIC MEDICINE
Atul Grover MD, Association of American Medical Colleges
Young Faculty Clinical Investigator Award
PANTOPRAZOLE PHARMACOKINETICS IN OBESITY: WHERE GENES AND SIZE COLLIDE.
Valentina Shakhnovich1,2, Susan Abdel-Rahman2, Craig Friesen1, Jaylene Weigel2, Robin E. Pearce2, Andrea Gaedigk2, J Steven Leeder2, Gregory L. Kearns2. 1Gastroenterology, Hepatology and Nutrition, Children's Mercy Hospital, Kansas City, MO, USA; 2Clinical Pharmacology, Toxicology and Therapeutic Innovation, Children's Mercy Hospital, Kansas City, MO, USA.
William Balistreri Prize
SELECTIVE SEROTONIN REUPTAKE INHIBITORS HAVE CRITICAL AND LONG-LASTING EFFECTS ON ENTERIC NERVOUS SYSTEM DEVELOPMENT AND GASTROINTESTINAL FUNCTION.
Virginia Saurman1, Korey Stevanovic1, Narek Israelyan1, Zi Shan Li2, Michael Gershon2, Isaac Snyder1, Kara G. Margolis1. 1Pediatrics, Columbia University Medical Center, New York, NY, USA; 2Pathology, Columbia University Medical Center, New York, NY, USA.
Gerald Odell Prize
HUMAN INDUCED PLURIPOTENT STEM CELL-DERIVED EXTRACELLULAR VESICLES REVERSE HEPATIC STELLATE CELL ACTIVATION.
Davide Povero1, Nidhi Goyal1, Lucas de Araujo Horcel1,2, Akiko Eguchi1, Paulina Ordonez1, Ariel E. Feldstein1.1University of California San Diego, La Jolla, CA, USA; 2Centro Universitario Lusiada, São Paulo, Brazil.
KEYNOTE ADDRESS: PERSPECTIVES FROM NIDDK RELATED TO NASPGHAN
Griffin P. Rodgers MD, MACP, Director, National Institute of Diabetes and Digestive and Kidney Disease
EMBRYOLOGY MEETS ENDOSCOPY: THE ROLE OF ENDOSCOPY IN CONGENITAL GASTROINTESTINAL MALFORMATIONS
Michael Manfredi MD, Children’s Hospital Boston
PEDIATRIC ERCP IN THE SETTING OF ACUTE PANCREATITIS: A REPORT FROM THE MULTICENTER PEDIATRIC ERCP DATABASE INITIATIVE.
David M. Troendle1,2, Quin Y. Liu3,4, Kyung Mo Kim6,5, Doug Fishman7,8, Matthew Giefer10,9, Michael Wilsey11, Racha Khalaf11, Bradley A. Barth1,2. 1Pediatrics, UT Southwestern, Dallas, TX, USA; 2Children's Health, Children's Medical Center, Dallas, TX, USA; 3University of Southern California, Los Angeles, CA, USA;4Children's Hospital of Los Angeles, Los Angeles, CA, USA; 5Asan Medical Center Children's Hospital, Seoul, Korea (the Republic of); 6University of Ulsan College of Medicine, Seoul, Korea (the Republic of); 7Baylor College of Medicine, Houston, TX, USA; 8Texas Children's Hospital, Houston, TX, USA; 9Seattle Children's Hospital, Seattle, TX, USA; 10University of Washington, Seattle, WA, USA; 11All Children's Hospital Johns Hopkins Medicine, St. Petersburg, FL, USA.
STATE OF THE ART RESEARCH LECTURE - BUILDING A CAREER IN PEDIATRIC ENDOSCOPY RESEARCH
Petar Mamula MD, Children’s Hospital of Philadelphia
FACTORS ASSOCIATED WITH INADEQUATE BOWEL PREPARATION FOR COLONOSCOPY IN CHILDREN - A PROSPECTIVE STUDY.
Sanjay Kumar, Courtney D. Gingerich, Emily Ferrell, Sandeep K. Gupta. Pediatric Gastroenterology, Riley Hospital for Children - Indiana University Health, Indianapolis, IN, USA.
THREE DIMENSIONAL PRINTING OF HUMAN LIVER FOR SURGICAL PLANNING AND BEYOND
Nizar Zein MD, The Cleveland Clinic
SURVIVAL OUTCOME SCORES (SOFT, BAR AND PEDI-SOFT) ARE ACCURATE IN PREDICTING POST-LIVER TRANSPLANT SURVIVAL IN ADOLESCENTS.
Praveen Kumar Conjeevaram Selvakumar3, Brian Maksimak3, Ibrahim Hanouneh1, Dalia H. Youssef3, Rocio Lopez2, Naim Alkhouri3. 1Gastroenterology and Hepatology, Cleveland Clinic, Cleveland, OH, USA;2Biostatistics, Quantitative Health Sciences, Cleveland Clinic, Cleveland, OH, USA; 3Pediatric Gastroenterology, Cleveland Clinic, Cleveland, OH, USA.
MECHANISMS OF HEPATIC STEATOSIS: DIAGNOSTIC AND THERAPEUTIC IMPLICATIONS
Ariel Feldstein MD, University of California, San Diego
MIXED LINEAGE KINASE 3 MEDIATES RELEASE OF C-X-C MOTIF CHEMOKINE 10-BEARING EXTRACELLULAR VESICLES FROM LIPOTOXIC HEPATOCYTES.
Samar H. Ibrahim1, Petra Hirsova2, Steven F. Bronk2, Nathan W. Werneberg2, Stephen A. Harrison3, Harmeet Malhi2, Gregory J. Gores2. 1Pediatric Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA;2Gastroenterology and Hepatology, Mayo Clinic, Rochester, MN, USA; 3Gastoenterology and Hepatology, Brooke Army Medical Center, Fort Sam Houston, TX, USA.
DEBATE: HEAL THE MUCOSA OR HEAL THE PATIENT?
Cary Sauer MD, Emory Children’s Center vs. Shehzad Saeed MD, Cincinnati Children’s Hospital Medical Center
NASPGHAN Foundation/Crohn’s and Colitis Foundation Young Investigator Development Award
A METAGENOMIC APPROACH TO DIAGNOSIS, INDUCTION AND MAINTENANCE OF DEEP REMISSION FOLLOWING EXCLUSIVE ENTERAL NUTRITION IN PEDIATRIC CROHN’S DISEASE
Johann Van Limbergen MD, MRCPCH, PhD, IWK Health Centre
STATE OF THE ART RESEARCH LECTURE - STATURAL GROWTH IMPAIRMENT IN PEDIATRIC CROHN’S DISEASE
Neera Gupta MD, MAS Weill Cornell Medical Center
NASPGHAN Foundation Fellow to Faculty Transition Award in IBD
OXIDATIVE STRESS AND THE GUT MICROBIOME IN IBD TRANSITION
Lindsey Albenberg MD, Children’s Hospital of Philadelphia
UPDATE ON CPT CODES AND ALTERNATIVE PAYMENT MECHANISMS
Joel Brill, MD, FAIR Health, Inc.
PRACTICE ECONOMICS: MISSION, MONEY, MIDAS AND MAGIC
David A. Piccoli MD, Children’s Hospital of Philadelphia
NASPGHAN WORKFORCE SURVEY RESULTS: HOW DO WE ALL STACK UP?
Linda Muir MD, FAAP, Oregon Health Science University
REGULATORY CONSIDERATIONS IN SELECTING AN ENDPOINT
Preeti Venkataraman MD, Food and Drug Administration
EUROPEAN MEDICINES AGENCY (EMA) PERSPECTIVE ON THE DEVELOPMENT OF NEW MEDICINES IN GASTROENTEROLOGY
Richard Veselý MD, European Medicines Agency, London, UK
CLINICALLY MEANINGFUL ENDPOINTS IN EoE
Glenn Furuta MD, Children’s Hospital Colorado
NUTRITIONAL ISSUES IN CHOLESTATIC DISEASE
Binita Kamath MBBChir MRCP MTR, The Hospital for Sick Children
NUTRITIONAL CHALLENGES IN CHILDREN WITH AUTISM
Cade M. Nylund, MD, MS, F. Edward Hébert School of Medicine Uniformed Services University
IRON DEFICIENCY AND THE DEVELOPING BRAIN
Michael Georgieff MD, University of Minnesota
“ISLET” THEM TAKE MY WHOLE PANCREAS!
Jaimie Nathan MD, Cincinnati Children’s Hospital Medical Center
EARLY ENTERAL NUTRITION AND AGRESSIVE FLUID RESUSCITATION ARE ASSOCIATED WITH IMPROVED CLINICAL OUTCOMES IN ACUTE PANCREATITIS.
Flora K. Szabo, Lin Fei, Ligia M. Alfaro Cruz, Maisam Abu-El-Haija. Cincinnati Children's Hospital, Cincinnati, OH, USA.
STATE OF THE ART RESEARCH LECTURE - SOLVING A PEDIATRIC DILEMMA: DRUG-INDUCED PANCREATITIS
Sohail Husain MD, Children's Hospital of Pittsburgh of UPMC & the University of Pittsburgh
NASPGHAN Pancreas Prize –Supported by a grant from JOLI Diagnostic
TARGETING PANCREATIC CALCINEURIN TO PREVENT POST-ERCP PANCREATITIS.
Abrahim I. Orabi, Tanveer A. Javed, Swati Sah, John F. Eisses, Shunqian Jin, Sohail Z. Husain. Pediatric Gastroenterology, University of Pittsburgh, Pittsburgh, PA, USA.
RECENT ADVANCES IN FECAL MICROBIOTA TRANSPLANT
David Suskind MD, Seattle Children’s Hospital
STOOL BILE ACID PROFILES IN PEDIATRIC PATIENTS WHO RECEIVED FMT FOR CLOSTRIDIUM DIFFICILE INFECTION.
Mary Elizabeth M. Tessier1, Faith D. Ihekweazu1, Dorottya Nagy-Szakal1, Jonathan Crews2, Cana Ross3, Numan Oezguen3, Hoonmo Koo4, Michael Wang1, Ruth A. Luna3, James Versalovic3, Richard Kellermayer1, Tor Savidge1,3. 1Pediatric Gastroenterology, Baylor College of Medicine/ Texas Children's Hospital, Houston, TX, USA; 2Pediatrics- Infectious Disease, Baylor College of Medicine/ Children's Hospital of San Antonio, San Antonio, TX, USA; 3Pathology, Baylor College of Medicine, Houston, TX, USA; 4Medicine- Infectious Disease, Baylor College of Medicine, Houston, TX, USA.
STATE OF THE ART RESEARCH LECTURE – THE PEDIATRIC GUT MICROBIOME: THE FORGOTTEN ORGAN
Sonia Michail MD, Children’s Hospital of Los Angeles
IMPACT OF TREATMENT ON THE ESOPHAGEAL MICROBIOTA AND BACTERIAL RECEPTOR EXPRESSION IN EOSINOPHILIC ESOPHAGITIS.
Sophie A. Fillon1, Jonathan K. Harris2, Lauren Henry1, Ha Na Choe1, Brandie Wagner2, Wendy Moore1, Katie Amsden3, Amir F. Kagalwalla3, Angelika Zalewski4, Ikuo Hirano4, Nirmala Gonsalves4, Kathryn A. Biette1, Joanne C. Masterson1, Steven J. Ackerman5, Glenn Furuta1. Pediatrics Gastroenterology, University of Colorado Denver, Aurora, CO, USA; 2Pediatrics, University of Colorado Denver, Aurora, CO, USA; 3Pediatrics, Northwestern University Chicago, Chicago, IL, USA; 4Gastroenterology and Hepatology, Northwestern University, Chicago, IL, USA; 5Biochemistry and Molecular Genetics, University of Illinois at Chicago, Chicago, IL, USA.
BRAIN-GUT INTERACTIONS: IMPLICATIONS IN NEUROGASTROENTEROLOGY
Kara Gross Margolis MD, Columbia University
NASPGHAN Motility Prize – Basic Science –Supported by a grant from MMS
IBUPROFEN SLOWS MIGRATION OF ENTERIC NERVOUS SYSTEM PRECURSOR CELLS INCREASING THE RISK OF HIRSCHSPRUNG-LIKE DISEASE IN ANIMAL MODELS.
Ellen M. Schill1,2, Jonathan I. Lake2, Olga Tusheva2, Nandor Nagy4,5, Saya K. Bery1, Lynne Foster6, Marina Avetisyan2, Stephen L. Johnson3, William F. Stenson6, Allan M. Goldstein4, Robert O. Heuckeroth1. 1Pediatrics, The Children's Hospital of Philadelphia and The Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA; 2Pediatrics, Washington University School of Medicine in St. Louis, St. Louis, MO, USA; 3Genetics, Washington University School of Medicine in St. Louis, St. Louis, MO, USA;4Pediatric Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA; 5Department of Human Morphology and Developmental Biology, Faculty of Medicine, Semmelweis University, Budapest, Hungary; 6Internal Medicine, Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
THE OVERLAP BETWEEN INFLAMMATORY BOWEL DISEASE AND FUNCTIONAL GASTROINTESTINAL DISORDERS: CHALLENGES AND TREATMENT IMPLICATIONS
Miguel Saps MD, Nationwide Children’s Hospital
NASPGHAN Motility Prize – Clinical Science – Supported by a grant from MMS
PARENT-ONLY INTERVENTION REDUCES SYMPTOMS AND DISABILITY IN ABDOMINAL PAIN PATIENTS.
Rona L. Levy1, Miranda Van Tilburg2, Shelby L. Langer1, Joan M. Romano3, Lloyd A. Mancl4, William E. Whitehead2, Shara A. Feld5, Lynn S. Walker6. 1School of Social Work, University of Washington, Seattle, WA, USA; 2Medicine, University of North Carolina, Chapel Hill, NC, USA; 3Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA, USA; 4Oral Health Sciences, University of Washington, Seattle, WA, USA; 5School of Medicine and Public Health, University of Wisconsin-Madison, Madison, WI, USA; 6Pediatrics, Vanderbilt University, Nashville, TN, USA.
IBD: IF MY PATIENT IS WELL ON COMBINATION THERAPY WHAT SHOULD I DO? BE HAPPY OR DE-ESCALATE THERAPY?
Andrew Grossman MD, Children’s Hospital of Philadelphia
LIVER TRANSPLANT AND IMMUNOSUPPRESSION: LESS OR NONE,SAFE OR SORRY?
Sandy Feng MD, PhD, University of California, San Francisco
SHOULD I TREAT EOSINOPHILIC ESOPHAGITIS AS A CHRONIC DISEASE?
Glenn Furuta MD, Children’s Hospital Colorado
PSYCHOSOCIAL ASPECTS OF CHRONIC GASTROENTEROLOGICAL ILLNESS
Bonnie Reed-Knight PhD, Emory University School of Medicine
WHAT HAPPENS BEHIND CLOSED DOORS: THE INS AND OUTS OF PSYCHOLOGICAL TREATMENTS
Katherine Lamparyk Pys.D, Cleveland Clinic Children’s
PSYCHOLOGY AND GASTROENTEROLOGY: KEYS TO EFFECTIVE INTEGRATION
Anthony Alioto PhD, BCB, Nationwide Children’s Hospital
IMPROVE CARE NOW: EXPANDING ON A DECADE OF LEARNING
Wallace Crandall MD, Nationwide Children’s Hospital
GENETIC VARIATION IN VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE.
Christopher J. Moran1, Judith Kelsen2, Jess L. Kaplan1, Hailiang Huang8, Manuel Rivas8, Noor Dawany9, Melvin B. Heyman3, Barbara Kirschner4, Thomas Mangatu4, Keith Benkov6, Jonathan E. Teitelbaum7, Stan Cohen12, Benjamin D. Gold12, Marcella Devoto10, Ramnik Xavier11, Robert Baldassano2, Mark J. Daly5, Harland S. Winter1. 1Pediatric Gastroenterology, MassGeneral Hospital for Children, Boston, MA, USA;2Pediatric Gastroenterology, Children's Hospital of Philadelphia, Philadelphia, PA, USA; 3Pediatric Gastroenterology, University of California, San Francisco, San Francisco, CA, USA; 4Pediatric Gastroenterology, The University of Chicago Medicine Comer Children's Hospital, Chicago, IL, USA; 5Analytical and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA; 6Pediatric Gastroenterology, The Mount Sinai Hospital, New York, NY, USA; 7Pediatric Gastroenterology, Monmouth Medical Center, Long Branch, NJ, USA; 8Broad Institute, Cambridge, MA, USA; 9Department of Biomedical and Health Informatics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; 10Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA; 11Gastroenterology, Massachusetts General Hospital, Boston, MA, USA; 12Children's Center for Digestive Health Care, Atlanta, GA, USA.
HEALTH MAINTENANCE OF IBD (VACCINATION/SKIN)
Paul Rufo MD, Children’s Hospital Boston
NASPGHAN Foundation Fellow to Faculty Transition Award in IBD
CMV INFECTION IN INDIVIDUALS WITH NK CELL LICENSING GENOTYPE PREDISPOSESTO INFLAMMATORY BOWEL DISEASE
Susy Yusung MD, Children’s Hospital, Los Angeles
LONG TERM MANAGEMENT OF THE POST PEDIATRIC LIVER TRANSPLANT PATIENT: SOMETHING FOR EVERYONE TO CARE ABOUT
Vicky Lee Ng MD, The Hospital for Sick Children
MICRORNA-181 PROMOTES GRAFT PROLONGATION BY PLASMACYTOID DENDRITIC CELLS BY INCREASING T REGULATORY CELLS AND DECREASING B CELLS AS REVEALED BY MASS CYTOMETRY (CYTOF).
Audrey H. Lau1, Matthew Vitalone2, Xiumei Qu2, Todd Shawler2, Olivia M. Martinez2, Carlos O. Esquivel2, Sheri M. Krams2. 1Pediatrics, Division of Gastroenterology, Hepatology, and Nutrition, LPCH/Stanford University, Stanford, CA, USA; 2Surgery, Stanford University, Stanford, CA, USA.
STATE OF THE ART RESEARCH LECTURE - UNIQUE ASPECTS OF NEONATAL IMMUNITY PROVIDE CLUES TO THE PATHOGENESIS OF BILIARY ATRESIA
Cara Mack MD, Children’s Hospital of Colorado
PROSPECTIVE ANALYSIS OF PRESENTING FEATURES OF NEONATAL CHOLESTASIS – LIMITATIONS IN PREDICTIVE MODELS OF BILIARY ATRESIA.
Benjamin Shneider1, John C. Magee2, Nanda Kerkar4, Jeffrey Moore5, Wen Ye5, Saul Karpen3, Peter Whitington6, Jorge Bezerra7, Paula Hertel1, Jean Molleston8, Kasper Wang9, Henry Lin10, Robert Squires11, Philip Rosenthal12, Vicky Ng13, Yumirle Turmelle14, Kathleen Schwarz15, Averell Sherker16, Ronald J. Sokol for ChiLDReN17. 1Pediatric Gastroenterology, Hepatology and Nutrition, Baylor College of Medicine, Houston, TX, USA; 2University of Michigan Medical School, Ann Arbor, MI, USA; 3Pediatric Gastroenterology, Hepatology and Nutrition, Emory University School of Medicine/Children's Healthcare of Atlanta, Atlanta, GA,USA;4Division of Gastroenterology, Hepatology and Nutrition, Childrens' Hospital of Los Angeles, University of Southern California, Los Angeles, CA, USA; 5Department of Biostatistics, University of Michigan, Ann Arbor, MI, USA; 6Pediatrics Division of Gastroenterology, Hepatology, and Nutrition,Ann and Robert H Lurie Children's Hospital of Chicago, Chicago, IL, USA; 7Division of Pediatric Gastroenterology, Hepatology and Nutrition, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; 8Department of Pediatrics, Department of Pediatric Gastroenterology, Hepatology and Nutrition, Indiana University School of Medicine, Indianapolis, IN, USA; 9Division of Pediatric Surgery, Children's Hospital Los Angeles, Los Angeles, CA, USA;10Children's Hospital of Philadelphia, Philadelphia, PA, USA; 11Children's Hospital of Pittsburgh, Pittsburgh, PA, USA; 12Division of Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, UCSF Benioff Children's Hospital, San Francisco, CA, USA; 13The Hospital for Sick Children, Toronto, ON, Canada;14Washington University School of Medicine, Saint Louis, MO, USA; 15Johns Hopkins School of Medicine, Baltimore, MD, USA; 16Liver Diseases Research Branch, National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD, USA; 17Section of Pediatric Gastroenterology, Hepatology and Nutrition, Department of Pediatrics, University of Colorado School of Medicine, Aurora, CO, USA.
NERD: A FOUR LETTER WORD?
Rachel Rosen MD, Boston Children’s Hospital
CLAUDIN-7 DYSREGULATION IN PEDIATRIC EOSINOPHILIC ESOPHAGITIS: A ROLE FOR TGF-β1 IN ESOPHAGEAL EPITHELIAL BARRIER DYSFUNCTION.
Shahan D. Fernando1, Kathryn A. Biette1, David A. Kitzenberg2, Louise E. Glover2, Sean P. Colgan2, Glenn Furuta1, Joanne C. Masterson1. 1Pediatrics, University of Colorado, Denver, CO, USA; 2Medicine, University of Colorado, Denver, CO, USA.
STATE OF THE ART RESEARCH LECTURE - MANIPULATING GUT BACTERIA TO PREVENT THE ONSET OF CELIAC DISEASE
Alessio Fasano MD, Massachusetts General Hospital for Children
NON-INVASIVE MONITORING OF INTESTINAL PERMEABILITY AND INFLAMMATION IN A PROSPECTIVE SEROLOGICAL DIAGNOSIS STUDY OF PEDIATRIC CELIAC DISEASE.
Seema Rajani1, Hien Q. Huynh1,2, Leanne Shirton2, Cheryl Kluthe2, Don Spady1, Connie Prosser5, Jon Meddings4, Gwendolyn Rempel3, Rabindranath Persad1,2, Justine Turner1,2. 1Pediatrics, University of Alberta, Edmonton, AB, Canada; 2Gastroenterology, Stollery Children's Hospital, Edmonton, AB, Canada; 3Nursing, University of Alberta, Edmonton, AB, Canada; 4Medicine, University of Calgary, Calgary, AB, Canada; 5Stollery Children's Hospital, Edmonton, AB, Canada.
ABDOMINAL PAIN: INTEGRATING PSYCHOLOGICAL TREATMENTS INTO MEDICAL CARE
Miranda vanTilburg PhD, University of North Carolina
CONSTIPATION AND SOILING: INTEGRATED MODELS OF CARE
Rose Schroedl PhD, Nationwide Children's Hospital
INTERDISCIPLINARY INPATIENT APPROACHES TO WEANING TUBE DEPENDENT CHILDREN FROM ENTERAL FEEDING
Alan Silverman PhD, Medical College of Wisconsin
WHEN IS INFORMED CONSENT REALLY INFORMED?
Jeannie Huang MD, University of California, San Diego
ETHICS AND ADVOCACY IN THE MODERN ERA OF PEDIATRIC LIVER TRANSPLANTATION IN THE UNITED STATES
Evelyn Hsu MD, Seattle Children's Hospital
THE ETHICS OF INVESTIGATIONAL AND COMPASSIONATE USES
Kevin Donovan MD, Georgetown School of Medicine
Sunday, October 11
HOW TO GET STARTED: YOUR FIRST STUDY
Maria Oliva - Hemker MD, Johns Hopkins University
PRACTICAL ASPECTS OF LIFE AS A PHYSICIAN-SCIENTIST: INNOVATION, FUNDING AND SUPPORT
Glenn Furuta MD, Children's Hospital Colorado
BRANDING: HOW TO ESTABLISH YOUR RESEARCH NICHE
Marla Dubinsky, Mount Sinai Medical Center
HOW TO LEVERAGE RESOURCES OF THE CTSA FOR YOUR RESEARCH
James Heubi MD, Cincinnati Children's Hospital Medical Center
TEAM SCIENCE: HOW TO DEVELOP AND LEAD A MULTICENTER STUDY AND HOW TO CLIMB THE LADDER ON THE TEAM
Karen Murray MD, Seattle Children's Hospital
UTILIZING SOCIAL MEDIA TO ADVANCE YOUR RESEARCH AGENDA
Eric Benchimol MD, Children's Hospital of Eastern Ontario
HOW TO BE A WONDERFUL MENTOR AND SPONSOR
Samuel Nurko MD, Children's Hospital Boston